Function-Centered Strategies for Cognitive Impairment and CVD in Aging Populations

Article Impact Level: HIGH
Data Quality: STRONG
Summary of  JACC https://doi.org/10.1016/j.jacc.2026.07.009 
Dr. Karen P. Alexander  et al.

Points

American College of Cardiology experts published a scientific statement reframing geriatric cardiovascular care toward an aging-informed model focused on functional independence.
Epidemiological estimates indicate that approximately one-third of cardiology clinic patients present with measurable baseline cognitive impairment during routine visits.
Clinical data show frailty affects roughly one-half of community-dwelling older adults and up to two-thirds of patients undergoing percutaneous coronary intervention.
Shared biological aging pathways including chronic inflammation, vascular dysfunction, and sarcopenia drive the co-occurrence of heart disease, frailty, and cognitive decline.
Clinicians should implement routine screening, structured cardiac rehabilitation, multidomain exercise programs, and targeted deprescribing strategies to limit polypharmacy harms.

Summary

This scientific statement evaluated the clinical convergence of cardiovascular disease (CVD), cognitive impairment, and frailty in older adults to establish an aging-informed, function-centered framework for cardiology practice. Formulated by an American College of Cardiology writing committee chaired by Karen P. Alexander, the consensus report emphasizes that these syndromes frequently coexist due to shared biological aging mechanisms, including vascular dysfunction, chronic systemic inflammation, sarcopenia, and depleted physiological reserve. The statement reframes geriatric cardiology decisions around functional independence rather than traditional disease-centric end points.

Epidemiological prevalence data demonstrate that approximately 33% (1/3) of outpatient cardiology clinic patients present with coexisting cognitive impairment. Furthermore, frailty affects approximately 50% (1/2) of community-dwelling older adults and rises to approximately 67% (2/3) among older patients undergoing percutaneous coronary intervention (PCI). These overlapping comorbidities impair treatment tolerance, medication compliance, and post-procedural recovery. The report advocates for systematic outpatient and post-hospitalization screening to identify unrecognized cognitive and physical declines.

Interventional recommendations emphasize promoting physiological resilience through structured multicomponent strategies, including cardiac rehabilitation, multidomain exercise protocols, nutritional optimization, and aggressive deprescribing to reduce polypharmacy-related adverse events. The authors conclude that clinical management must prioritize biological age over chronological metrics, while calling for clinical trial designs that explicitly incorporate older cohorts and measure patient-centered outcomes, including functional mobility, cognitive trajectory, and caregiver burden.

Link to the article: https://www.jacc.org/doi/10.1016/j.jacc.2026.07.009

References

Alexander, K. P., Damluji, A. A., Erqou, S., Ferrucci, L., Forman, D. E., Galasko, D., & Yaffe, K. (2026). Cognitive impairment and frailty in older adults with cardiovascular disease: 2026 acc scientific statement. JACC, S0735109726071263. https://doi.org/10.1016/j.jacc.2026.07.009